387482003: Nadolol (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Nadolol (substance)

\Drug or medicament (substance)\Autonomic agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Nadolol (substance)
\Drug or medicament (substance)\agent cardiovasculaire\Hypotensive agent (substance)\Substance with beta adrenergic receptor antagonist mechanism of action (substance)\Nadolol (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Nadolol (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Amine\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Nadolol (substance)
\Organic compound\Substance with alcohol structure (substance)\Amino alcohol (substance)\Alkanolamine (substance)\Propanolamine (substance)\Nadolol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Nadolol (substance)	Is a	Non-selective beta-blocking agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol (substance)	Is a	Propanolamine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol (substance)	Has disposition	Beta adrenergic receptor antagonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol (substance)	Is a	Substance with beta adrenergic receptor antagonist mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nadolol measurement	Component	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol adverse reaction	Causative agent (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to nadolol (finding)	Causative agent (attribute)	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol+diuretic	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol 120 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely nadolol 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol 160 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Nadolol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide + nadolol 5mg/40mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide + nadolol 5mg/80mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bendroflumethiazide- and nadolol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide + nadolol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Allergy to nadolol (finding)	Causative agent (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 40 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 80 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has basis of strength substance (attribute)	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Nadolol 120 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 120 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely nadolol 20 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely nadolol 20 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 160 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 160 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has basis of strength substance (attribute)	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 120 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 40 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely nadolol 20 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 80 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol 160 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has precise active ingredient	False	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Nadolol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only bendroflumethiazide and nadolol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Nadolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide and nadolol only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet	Has precise active ingredient	True	Nadolol (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461660010	Nadolol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481573011	Nadolol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1461660010	Nadolol (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1461660010	Nadolol (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481573011	Nadolol	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1481573011	Nadolol	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
58401000195117	nadololo	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
73491000195116	Nadolol	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
826711000172118	nadolol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
826711000172118	nadolol	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
58401000195117	nadololo	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
73491000195116	Nadolol	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module